As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

MRSA is an antimicrobial resistance (AMR) superbug that causes over 120,000 deaths per year. Given the urgent need for new, more effective antibiotics and a lack of MRSA vaccines, understanding ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that is highly resistant to common antibiotics. Many people carry the MRSA bacteria harmlessly on their skin ...

Whenever possible, the narrowest spectrum antibiotics should be used to treat an identified MRSA infection and, when it is cured, they should be discontinued as soon as possible. Furthermore ...

MRSA is a type of staph highly resistant to a common class of antibiotics. Many people carry MRSA harmlessly on their skin or inside their noses. However, if the bacteria penetrates the skin ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...